Archive for 2016

  • aside

    EXTRA BOLAGSSTÄMMA I ISOFOL MEDICAL AB

    Aktieägarna i Isofol Medical AB kallas härmed till extra bolagsstämma onsdagen den 21 december 2016 klockan 15.00 på Isofol Medical…

    by
  • aside

    Isofol Medical present at Aktietorget investor meeting

    Isofol Medical AB presented at the AktieTorget investor meeting on Wednesday, October 5. This was a meeting arranged by SvD…

    by
  • aside

    Isofol Medical has successfully advanced to the next dose level of Modufolin® in a phase I/II clinical trial in colorectal cancer.

    Isofol Medical AB today announced initiation of the next dose level of Modufolin®, in combination with 5-FU and oxaliplatin or…

    by
  • aside

    Isofol announces successful meetings with European and US regulatory authorities regarding the design of a pivotal Phase II clinical trial of Isofol’s lead Drug candidate, Modufolin®

    Isofol Medical AB, a clinical stage pharmaceutical company, developing novel products for unmet needs within oncology is pleased with the…

    by
  • aside

    Isofol Medical share issue oversubscribed, securing over SEK 39 million to strengthen the ongoing Phase II clinical development program of Modufolin®

    Isofol Medical AB, a clinical stage pharmaceutical company, developing novel products for unmet needs within oncology, will use the investment…

    by